VERSANT HCV RNA QUALITATIVE ASSAY/APTIMA HCV RNA QUALITATIVE ASSAY
FDA premarket approval P020011/S007 · decided 2013-04-08
Approval details
- PMA number
- P020011
- Supplement
- S007
- Supplement type
- 30-Day Notice
- Trade name
- VERSANT HCV RNA QUALITATIVE ASSAY/APTIMA HCV RNA QUALITATIVE ASSAY
- Generic name
- Assay, hybridization and/or nucleic acid amplification for detection of hepatitis c rna,hepatitis c virus
- Applicant
- Gen-Probe
- Date received
- 2013-03-13
- Decision date
- 2013-04-08
- Days to decision
- 26 days
- Decision code
- OK30
- Product code
- MZP
- Advisory committee
- Microbiology
- Expedited review
- No
- Location
- San Diego, CA
- Statement
- CHANGE FOR MODIFICATION OF A QUALITY CONTROL (QC) PANEL MEMBER WHICH WILL BE USED IN RELEASE TESTING OF THE FINAL APPROVED DEVICE.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.